GLP-1 Stocks Aren’t the Only Way to Benefit From the Weight Loss Drugs Boom
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
By now, nearly everyone has heard of the weight loss drugs targeted at the glucagon-like protein 1 (GLP-1) receptor, like Zepbound and Wegovy by Eli Lilly and Novo Nordisk, respectively. It’s no surprise why they’re household names; those medicines are bringing in billions of rev
:max_bytes(150000):strip_icc():format(jpeg)/WheretoInvestinRealEstateforRetirementIncome-900df0fb0ad446619a237c77ca63d483.jpg "Unlock Steady Retirement Income: Top Real Estate Investment Spots Revealed")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-103919679-fd1cf324b2b140ea99798d1b594faf4c.jpg "What Is Discretionary Income? How to Calculate, With Example")